Acellular dermal matrix for one-stage treatment of lower extremity full-thickness skin defect: a case series
Abstract Background Self-repair of lower limb wounds has always been one of the research hotspots. Flaps and skin graft are the preferred treatment for lower extremity wound reconstruction. However, these treatments have many disadvantages, such as secondary damage, poor healing quality. In recent years, the use of acellular dermal matrix has emerged as an alternative treatment option for extremity ulcers. Methods This study aimed to explore whether acellular dermal matrix can be used as a single treatment to promote wound healing. 7 patients with lower extremities cutaneous deficiency exposing bone or tendon, were covered by Pelnac, which was an acellular dermal matrix product approved by China Food and Drug Administration. All the wound was treated by Pelnac without flaps and skin graft. The external dressing was changed every 10 days. Results After a maximum of 20 weeks, all the wounds were completely healed. During the 12 months follow-up period none of the patients developed skin wear on the treatment area. All patients maintained their postoperative ambulatory ability. All patients were satisfied with the appearance and feeling after wound healing. Conclusion These findings may mean acellular dermal matrix is a novel method offering opportunity for treatment of lower extremities cutaneous deficiency exposing bone or tendon. It also has the potential to close wounds of all uninfected, non-ischemic, full-thickness cutaneous deficiency..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
BMC Surgery - 23(2023), 1, Seite 6 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gongchi Li [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Acellular dermal matrix |
|---|
| doi: |
10.1186/s12893-022-01871-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ081405464 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ081405464 | ||
| 003 | DE-627 | ||
| 005 | 20230310213702.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230310s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12893-022-01871-x |2 doi | |
| 035 | |a (DE-627)DOAJ081405464 | ||
| 035 | |a (DE-599)DOAJd5422641a28f4817b96157e9138860d9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RD1-811 | |
| 100 | 0 | |a Gongchi Li |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Acellular dermal matrix for one-stage treatment of lower extremity full-thickness skin defect: a case series |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background Self-repair of lower limb wounds has always been one of the research hotspots. Flaps and skin graft are the preferred treatment for lower extremity wound reconstruction. However, these treatments have many disadvantages, such as secondary damage, poor healing quality. In recent years, the use of acellular dermal matrix has emerged as an alternative treatment option for extremity ulcers. Methods This study aimed to explore whether acellular dermal matrix can be used as a single treatment to promote wound healing. 7 patients with lower extremities cutaneous deficiency exposing bone or tendon, were covered by Pelnac, which was an acellular dermal matrix product approved by China Food and Drug Administration. All the wound was treated by Pelnac without flaps and skin graft. The external dressing was changed every 10 days. Results After a maximum of 20 weeks, all the wounds were completely healed. During the 12 months follow-up period none of the patients developed skin wear on the treatment area. All patients maintained their postoperative ambulatory ability. All patients were satisfied with the appearance and feeling after wound healing. Conclusion These findings may mean acellular dermal matrix is a novel method offering opportunity for treatment of lower extremities cutaneous deficiency exposing bone or tendon. It also has the potential to close wounds of all uninfected, non-ischemic, full-thickness cutaneous deficiency. | ||
| 650 | 4 | |a Wound regeneration | |
| 650 | 4 | |a Acellular dermal matrix | |
| 650 | 4 | |a One-stage repair | |
| 653 | 0 | |a Surgery | |
| 700 | 0 | |a Qian Shen |e verfasserin |4 aut | |
| 700 | 0 | |a Pan Zhou |e verfasserin |4 aut | |
| 700 | 0 | |a Hanlin Liu |e verfasserin |4 aut | |
| 700 | 0 | |a Jianghai Chen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t BMC Surgery |d BMC, 2003 |g 23(2023), 1, Seite 6 |w (DE-627)DOAJ000133590 |x 14712482 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:1 |g pages:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12893-022-01871-x |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/d5422641a28f4817b96157e9138860d9 |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12893-022-01871-x |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1471-2482 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 1 |h 6 | ||